Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
RESEARCH TOOLSreports
BioMarin Pharmaceutical (BMRN) Ownership - Who Owns BioMarin Pharmaceutical?
1,782 Followers
BioMarin Pharmaceutical (BMRN) Ownership Overview
1.27% Insiders
40.32% Mutual Funds
19.77% Other Institutional Investors
38.64% Public Companies and
Individual Investors
The ownership structure of BioMarin Pharmaceutical (BMRN) stock is a mix of institutional, retail and individual investors. Approximately 60.09% of the company’s stock is owned by Institutional Investors, 1.27% is owned by Insiders and 38.64% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 07, 2024 | Jean Jacques Bienaime Director | Sold | $172220 |
| Mar 07, 2024 | Henry Fuchs President, Worldwide R&d | Sold | $3010346 |
| Feb 29, 2024 | Jean Jacques Bienaime Director | Sold | $90350 |
| Feb 12, 2024 | Jean Jacques Bienaime Director | Bought | $3704 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $3953 | |
| Dec 31, 2023 | Sold | $235843 | |
| Dec 31, 2023 | Sold | $239410 | |
| Dec 31, 2023 | Bought | $1279107 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,414,374 | Institution | 9.70% | 1,695,227,270 | |
| 17,308,863 | Institution | 9.12% | 1,593,453,928 | |
| 16,191,986 | Institution | 8.53% | 1,490,634,231 | |
| 13,994,063 | Institution | 7.37% | 1,288,293,440 | |
| 10,543,625 | Institution | 5.56% | 970,646,118 | |
| 6,826,903 | Institution | 3.60% | 628,484,690 | |
| 5,970,149 | Institution | 3.15% | 549,611,917 | |
| 5,909,896 | Institution | 3.11% | 544,065,026 | |
| 5,371,580 | Institution | 2.83% | 494,507,655 | |
| 4,889,454 | Institution | 2.58% | 450,123,135 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 16,191,986 | Institution | 8.53% | 1,490,634,231 | |
| 10,543,625 | Institution | 5.56% | 970,646,118 | |
| 6,826,903 | Institution | 3.60% | 628,484,690 | |
| 5,909,896 | Institution | 3.11% | 544,065,026 | |
| 5,371,580 | Institution | 2.83% | 494,507,655 | |
| 3,628,266 | Institution | 1.91% | 334,018,168 | |
| 2,166,300 | Institution | 1.14% | 199,429,578 | |
| 1,878,266 | Institution | 0.99% | 172,913,168 | |
| 1,849,348 | Institution | 0.97% | 170,250,977 | |
| 1,768,768 | Institution | 0.93% | 162,832,782 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,926,238 | Institution | 3.12% | 517,597,627 | |
| 4,090,309 | Institution | 2.16% | 357,247,588 | |
| 2,815,836 | Institution | 1.48% | 245,935,116 | |
| 1,812,090 | Institution | 0.95% | 158,267,941 | |
| 1,387,283 | Institution | 0.73% | 127,713,273 | |
| 1,338,105 | Institution | 0.71% | 116,870,091 | |
| 956,281 | Institution | 0.50% | 87,212,827 | |
| 873,555 | Institution | 0.46% | 80,419,473 | |
| 692,993 | Institution | 0.37% | 62,417,880 | |
| 692,993 | Institution | 0.37% | 62,417,880 |
FAQ
Who Owns BioMarin Pharmaceutical (BMRN)?
According to the latest TipRanks data, approximately 19.77% of the company's stock is held by institutional investors, 1.27% is held by insiders, and 38.64% is held by retail investors.
What percentage of BioMarin Pharmaceutical (BMRN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 19.77% of BioMarin Pharmaceutical (BMRN) stock is held by institutional investors.
What percentage of BioMarin Pharmaceutical (BMRN) stock is held by retail investors?
According to the latest TipRanks data, approximately 38.64% of BioMarin Pharmaceutical (BMRN) stock is held by retail investors.
Who owns the most shares of BioMarin Pharmaceutical (BMRN)?
Theofanis Kolokotrones owns the most shares of BioMarin Pharmaceutical (BMRN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.